Back
Day Range
$0.86
$0.86
52-Week Range
$0.52
$1.00
Volume
852
50D / 200D Avg
$0.80
/
$0.80
Prev Close
$0.86
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -13.8 | 0.4 |
| P/B | 3.5 | 2.9 |
| ROE % | -22.2 | 3.8 |
| Net Margin % | -22.4 | 3.9 |
| Rev Growth 5Y % | -20.9 | 10.0 |
| D/E | 1.0 | 0.2 |
Key Takeaways
Revenue declined -20.87% annually over 5 years
Negative free cash flow of -343.18M
PEG of 0.31 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.66%
Capital efficient — spends only 0.00% of revenue on capex
Growth
Revenue Growth (5Y)
-20.87%
Revenue (1Y)-12.21%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-22.23%
ROIC-9.55%
Net Margin-22.40%
Op. Margin-22.52%
Safety
Debt / Equity
0.98
Current Ratio1.60
Interest Coverage-6.05
Valuation
P/E Ratio
-13.79
P/B Ratio3.46
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12.21% | Revenue Growth (3Y) | -8.02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -20.87% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 407.21M | Net Income (TTM) | -91.21M |
| ROE | -22.23% | ROA | -6.55% |
| Gross Margin | 58.98% | Operating Margin | -22.52% |
| Net Margin | -22.40% | Free Cash Flow (TTM) | -343.18M |
| ROIC | -9.55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.98 | Current Ratio | 1.60 |
| Interest Coverage | -6.05 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.79 | P/B Ratio | 3.46 |
| P/S Ratio | 3.09 | PEG Ratio | 0.31 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.26B | Enterprise Value | 1.23B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 407.21M | 463.84M | 481.36M | 243.72M | 1.04B |
| Net Income | -91.21M | -367.23M | -902.68M | -1.92B | -1.22B |
| EPS (Diluted) | -0.07 | -0.29 | -0.77 | -1.65 | -1.17 |
| Gross Profit | 240.15M | 304.30M | 278.38M | 136.89M | 797.41M |
| Operating Income | -91.69M | -579.85M | -912.15M | -1.83B | -1.09B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1.39B | 1.66B | 1.64B | 2.27B | 3.76B |
| Total Liabilities | 1.03B | 1.21B | 1.19B | 1.06B | 808.29M |
| Shareholders' Equity | 363.87M | 456.83M | 449.33M | 1.21B | 2.95B |
| Total Debt | 355.97M | 363.45M | 286.29M | 174.20M | 83.86M |
| Cash & Equivalents | 387.94M | 996.67M | 558.68M | 742.72M | 3.02B |
| Current Assets | 1.09B | 1.33B | 1.25B | 1.96B | 3.57B |
| Current Liabilities | 682.01M | 850.34M | 946.48M | 932.95M | 727.05M |